Please assess the completion status of the following clinical trial:

Trial Title: Synbiotics Cohort Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Aged \<13 months~* Confirmed or suspected CMA- based on healthcare professional (HCP) judgement~* At baseline, parent(s) must already be exclusively or partially formula feeding their child (with a hypoallergenic or non-hypoallergenic formula) or have already made the decision to start exclusively or partially formula feeding~* Recently prescribed a hypoallergenic formula containing synbiotics~Exclusion Criteria:~* Exclusively breastfed infants~* Primary lactose intolerance~* Enterally fed infants~* Premature infants (born \<37 weeks) with a corrected age of less than 1 month~* Infants with contraindications to the use of hyopallergenic formula containing synbiotics~* Major hepatic or renal dysfunction~* Investigator concern around the ability of family to comply with protocol and requirements of study

- Gender: ALL
- Minimum Age: 0 Months
- Maximum Age: 13 Months
- Healthy Volunteers: f

Study Arms:
- Hypoallergenic formula containing synbiotics (Type: None): Infants (aged \<13 months) with cow's milk allergy (CMA) who are prescribed a hypoallergenic formula containing synbiotics as part of usual clinical practice for the dietary management of CMA.

Based on this trial design, predict the completion outcome and termination type (if applicable).